Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125559161 | 12555916 | 1 | I | 20160629 | 20160714 | 20160714 | EXP | US-SUN PHARMACEUTICAL INDUSTRIES LTD-2016US-120180 | RANBAXY | 60.00 | YR | F | Y | 0.00000 | 20160714 | OT | GB | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125559161 | 12555916 | 1 | PS | Atorvastatin | ATORVASTATIN | 1 | Unknown | UNK | Y | 76477 | |||||||||
125559161 | 12555916 | 2 | I | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Unknown | UNK | Y | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125559161 | 12555916 | 1 | Hyperlipidaemia |
125559161 | 12555916 | 2 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125559161 | 12555916 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125559161 | 12555916 | Drug interaction | |
125559161 | 12555916 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |